SIMPONI ARIA® (golimumab) Approved by the U.S. Food and …
https://www.jnj.com/media-center/press-releases/simponi-aria-golimumab-approved-by-the-u-s-food-and-drug-administration-for-active-polyarticular-juvenile-idiopathic-arthritis-and-extension-of-its-active-psoriatic-arthritis-indication-in-patients-2-years-of-age-and-older
WebHORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI ARIA ® (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient …
DA: 87 PA: 55 MOZ Rank: 73